Abstract:Matrine (MT) possesses anti-inflammatory, anti-allergic and antioxidative properties. However, the impact and underlying mechanisms of matrine on colitis are unclear. The purpose of this research was to examine the protective impact and regulatory mechanism of matrine on dextran sulfate sodium (DSS)-induced ulcerative colitis (UC) in mice. MT alleviated DSS-induced UC by inhibiting weight loss, relieving colon shortening and reducing the disease activity index (DAI). Moreover, DSS-induced intestinal injury and the number of goblet cells were reversed by MT, as were alterations in the expression of zonula occludens-1 (ZO-1) and occludin in colon. Simultaneously, matrine not only effectively restored DSS-induced oxidative stress in colonic tissues but also reduced the production of inflammatory cytokines. Furthermore, MT could treat colitis mice by regulating the regulatory T cell (Treg)/T helper 17 (Th17) cell imbalance. We observed further evidence that MT alleviated the decrease in intestinal flora diversity, reduced the proportion of Firmicutes and Bacteroidetes, decreased the proportion of Proteobacteria and increased the relative abundance of Lactobacillus and Akkermansia in colitis mice. In conclusion, these results suggest that MT may mitigate DSS-induced colitis by enhancing the colon barrier integrity, reducing the Treg/Th17 cell imbalance, inhibiting intestinal inflammation, modulating oxidative stress and regulating the gut microbiota. These findings provide strong evidence for the development and application of MT as a dietary treatment for UC.

What problem does this paper attempt to address?

Based on the provided literature abstract and partial content, the problem that this paper attempts to solve is to explore the protective effect of matrine (MT) on dextran sulfate sodium (DSS) - induced ulcerative colitis (UC) in mice and its underlying regulatory mechanisms. Specifically, the study aims to evaluate whether matrine can relieve DSS - induced UC symptoms by inhibiting inflammation, regulating oxidative stress, improving intestinal barrier function, and modulating the gut microbiota. ### Main research questions: 1. **Protective effect of matrine on DSS - induced UC**: Investigate whether matrine can alleviate the symptoms of DSS - induced UC in mice, such as weight loss, colon shortening, and an increase in the disease activity index (DAI). 2. **Anti - inflammatory effect of matrine**: Evaluate whether matrine can reduce the production of inflammatory cytokines, such as tumor necrosis factor - α (TNF - α), interleukin - 6 (IL - 6), IL - 17A, IL - 1β, and nitric oxide (NO), while increasing the level of the anti - inflammatory cytokine IL - 10. 3. **Antioxidant effect of matrine**: Study whether matrine can reduce DSS - induced oxidative stress by measuring the levels of malondialdehyde (MDA), superoxide dismutase (SOD), catalase (CAT), and total antioxidant capacity (T - AOC). 4. **Effect of matrine on the intestinal barrier**: Evaluate whether matrine can protect the intestinal barrier function by up - regulating the expression of tight junction proteins such as ZO - 1 and occludin. 5. **Regulation of the Treg/Th17 cell balance by matrine**: Investigate whether matrine can inhibit the inflammatory response by regulating the ratio of regulatory T cells (Treg) and helper T cells 17 (Th17). 6. **Regulation of the gut microbiota by matrine**: Analyze whether matrine can improve UC symptoms by changing the structure and diversity of the gut microbiota, especially increasing the relative abundance of beneficial bacteria such as Lactobacillus and Akkermansia, and reducing the proportion of harmful bacteria. ### Research methods: - **Animal model**: Use the DSS - induced mouse UC model. - **Experimental design**: Divide the mice into a control group (CON), a DSS group, and different - dose matrine treatment groups. - **Index detection**: Include body weight change, DAI score, colon length, histopathological analysis, inflammatory cytokine levels, oxidative stress indicators, tight junction protein expression, and the composition and diversity of the gut microbiota. ### Conclusion: The research results show that matrine can significantly relieve DSS - induced UC symptoms and play a role through multiple mechanisms, including inhibiting inflammation, regulating oxidative stress, protecting intestinal barrier function, regulating the Treg/Th17 cell balance, and improving the gut microbiota. These findings provide a theoretical basis for matrine as a potential therapeutic drug for UC.

Matrine Ameliorates DSS-Induced Colitis by Suppressing Inflammation, Modulating Oxidative Stress and Remodeling the Gut Microbiota